Market Tracker

04/21 7:22am ET

Novavax Inc (NASDAQ:NVAX)

8.29
Delayed Data
As of Apr 20
 +0.22 / +2.73%
Today’s Change
3.70
Today|||52-Week Range
9.95
+39.80%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close8.07
Today’s open8.12
Day’s range-- - --
Volume2,766,666
Average volume (3 months)4,999,199
Market cap$2.2B
Dividend yield--
Data as of 04/20/2015

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-26.66%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book8.39

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...-0.35-0.35%
HALOHalozyme Therapeutic...+0.59+3.86%
OPHTOphthotech Corp-0.28-0.55%
FMIFoundation Medicine ...+0.34+0.69%
Data as of 04/20/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts